Juvenile Localized Scleroderma. Questions of Treatment
Juvenile localized scleroderma (JLS) is a group of childhood diseases with the main symptom — skin and subcutaneous structures lesions, without any organ involvement. There is active (inflammatory) and fibrotic phase in development of JLS. The JLS treatment during active phase (when skin lesions are...
Main Authors: | Rinat K. Raupov, Mikhail M. Kostik |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2020-08-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/2397 |
Similar Items
-
Juvenile Localized Scleroderma from the Perspective of Pediatric Rheumatologist. Aspects of Diagnostics
by: Rinat K. Raupov, et al.
Published: (2020-06-01) -
EXPERIENCE OF RITUXIMAB TREATMENT IN A PATIENT WITH JUVENILE SCLERODERMA
by: E. I. Alexeeva, et al.
Published: (2012-05-01) -
Combination therapy with leflunomide and genetic engineering biological agents
by: Nataliya Vladimirovna Chichasova, et al.
Published: (2011-06-01) -
Clinical and X-ray diagnostic criteria for maxillofacial damage in children with juvenile limited scleroderma
by: A. A. Skakodub, et al.
Published: (2020-05-01) -
Giant cell arteritis. Part II. Treatment
by: Azamat Makhmudovich Satybaldyev
Published: (2012-12-01)